Free Trial

Macerich (NYSE:MAC) Announces Earnings Results

Macerich logo with Finance background

Macerich (NYSE:MAC - Get Free Report) posted its quarterly earnings data on Wednesday. The real estate investment trust reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.90), Zacks reports. The business had revenue of $220.20 million for the quarter, compared to analysts' expectations of $208.54 million. Macerich had a return on equity of 3.15% and a net margin of 8.98%. Macerich's revenue for the quarter was up .9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.44 earnings per share.

Macerich Price Performance

NYSE:MAC traded up $0.22 during trading hours on Friday, reaching $19.52. 1,476,323 shares of the company's stock were exchanged, compared to its average volume of 1,418,307. The company has a quick ratio of 0.86, a current ratio of 0.92 and a debt-to-equity ratio of 1.68. The company has a market capitalization of $4.22 billion, a P/E ratio of 50.07, a price-to-earnings-growth ratio of 0.62 and a beta of 2.50. Macerich has a 12 month low of $9.90 and a 12 month high of $20.27. The business's 50-day simple moving average is $17.62 and its two-hundred day simple moving average is $16.05.

Macerich Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Tuesday, November 12th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 3.48%. The ex-dividend date of this dividend is Tuesday, November 12th. Macerich's dividend payout ratio is presently 174.36%.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Compass Point upped their price target on shares of Macerich from $20.00 to $23.00 and gave the company a "buy" rating in a report on Thursday. Evercore ISI increased their price target on shares of Macerich from $15.00 to $16.00 and gave the stock an "in-line" rating in a research report on Wednesday, August 28th. The Goldman Sachs Group boosted their price objective on Macerich from $13.00 to $14.60 and gave the company a "sell" rating in a report on Thursday, September 19th. StockNews.com downgraded Macerich from a "hold" rating to a "sell" rating in a report on Thursday. Finally, Piper Sandler upped their price target on Macerich from $11.00 to $14.00 and gave the company an "underweight" rating in a research report on Tuesday, September 3rd. Five equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, Macerich has a consensus rating of "Hold" and a consensus target price of $16.40.

Check Out Our Latest Report on Macerich

About Macerich

(Get Free Report)

Macerich is a fully integrated, self-managed and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich's portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, DC corridor.

See Also

Earnings History for Macerich (NYSE:MAC)

Should you invest $1,000 in Macerich right now?

Before you consider Macerich, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Macerich wasn't on the list.

While Macerich currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines